MedTrace Logo

EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)

NCT07096895 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-07-31

No results posted yet for this study

Summary

Safety and efficacy of EDEE (EUS-directed transenteric ERCP)

Conditions

  • Biliary Intervention
  • Altered Anatomy
  • Malignant Gastric Outlet Obstruction
  • EUS Guided Enteroenteric Anastomosis
  • EDEE

Interventions

PROCEDURE

EDEE (EUS-directed transenteric ERCP)

Technical aspects of EUS-guided anastomosis and ERCP via LAMS (Lumen apposing metal stent)

Sponsors & Collaborators

  • Evangelisches Krankenhaus Düsseldorf

    lead OTHER

Principal Investigators

  • Torsten PD Dr. med Beyna · Evangelisches Krankenhaus Düsseldorf

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2027-01-01
Completion
2027-01-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07096895 on ClinicalTrials.gov